Literature DB >> 30320429

A feasibility study of breast cancer genetic risk assessment in a federally qualified health center.

Kent F Hoskins1,2, Silvia Tejeda2, Ganga Vijayasiri2, Ifeanyi Beverly Chukwudozie2, Mylene H Remo1, Hiral A Shah1, Ivy E Abraham1, Lara E Balay1, Tara K Maga1, Ericka R Searles3, Veena J Korah3, Alana Biggers4, Melinda R Stolley2,5, Richard B Warnecke2.   

Abstract

BACKGROUND: The US Preventive Services Task Force (USPSTF) endorses routine screening for genetic risk of breast and/or ovarian cancer as a component of primary health care. Implementation of this recommendation may prove challenging, especially in clinics serving disadvantaged communities.
METHODS: The authors tested the feasibility of implementing the USPSTF mandate at a federally qualified health center (FQHC) to identify women who were eligible for genetic counseling (GC). A 12-month usual-care phase was followed by a 12-month intervention phase, during which time cancer genetic risk assessment (CGRA) was systematically performed for all women aged 25 to 69 years who presented for an annual examination. Women who were eligible for GC were recruited to participate in the study.
RESULTS: After initiating CGRA, 112 women who were eligible for GC consented to study participation, and 56% of them received a referral for GC from their primary care physician. A subgroup of 50 participants were seen by the same primary care physician during both the usual-care and intervention phases. None of these patients was referred for GC during usual care, compared with 64% after the initiation of CGRA (P < .001). Only 16% of referred participants attended a GC session.
CONCLUSIONS: Implementing USPSTF recommendations for CGRA as a standard component of primary health care in FQHCs is feasible and improves referral of minority women for GC, but more work is needed to understand the beliefs and barriers that prevent many underserved women from accessing cancer genetic services.
© 2018 American Cancer Society.

Entities:  

Keywords:  breast cancer; genetic counseling; genetic susceptibility; health disparities; risk assessment

Mesh:

Year:  2018        PMID: 30320429      PMCID: PMC6214782          DOI: 10.1002/cncr.31635

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  35 in total

1.  Health Care Segregation, Physician Recommendation, and Racial Disparities in BRCA1/2 Testing Among Women With Breast Cancer.

Authors:  Anne Marie McCarthy; Mirar Bristol; Susan M Domchek; Peter W Groeneveld; Younji Kim; U Nkiru Motanya; Judy A Shea; Katrina Armstrong
Journal:  J Clin Oncol       Date:  2016-05-09       Impact factor: 44.544

2.  A randomized, controlled trial to increase discussion of breast cancer in primary care.

Authors:  Celia P Kaplan; Jennifer Livaudais-Toman; Jeffrey A Tice; Karla Kerlikowske; Steven E Gregorich; Eliseo J Pérez-Stable; Rena J Pasick; Alice Chen; Jessica Quinn; Leah S Karliner
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-04-24       Impact factor: 4.254

3.  Validation studies for models projecting the risk of invasive and total breast cancer incidence.

Authors:  J P Costantino; M H Gail; D Pee; S Anderson; C K Redmond; J Benichou; H S Wieand
Journal:  J Natl Cancer Inst       Date:  1999-09-15       Impact factor: 13.506

Review 4.  Application of breast cancer risk prediction models in clinical practice.

Authors:  Susan M Domchek; Andrea Eisen; Kathleen Calzone; Jill Stopfer; Anne Blackwood; Barbara L Weber
Journal:  J Clin Oncol       Date:  2003-02-15       Impact factor: 44.544

5.  Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.

Authors:  M H Gail; L A Brinton; D P Byar; D K Corle; S B Green; C Schairer; J J Mulvihill
Journal:  J Natl Cancer Inst       Date:  1989-12-20       Impact factor: 13.506

6.  Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2014-02-18       Impact factor: 25.391

7.  Patient-reported hereditary breast and ovarian cancer in a primary care practice.

Authors:  John M Quillin; Alexander H Krist; Maria Gyure; Rosalie Corona; Vivian Rodriguez; Joseph Borzelleca; Joann N Bodurtha
Journal:  J Community Genet       Date:  2013-07-20

8.  Diffusion of breast cancer risk assessment in primary care.

Authors:  Carmen E Guerra; Melani Sherman; Katrina Armstrong
Journal:  J Am Board Fam Med       Date:  2009 May-Jun       Impact factor: 2.657

9.  American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.

Authors: 
Journal:  J Clin Oncol       Date:  2003-04-11       Impact factor: 44.544

10.  Genetic assessment of breast cancer risk in primary care practice.

Authors:  Wylie Burke; Julie Culver; Linda Pinsky; Sarah Hall; Susan E Reynolds; Yutaka Yasui; Nancy Press
Journal:  Am J Med Genet A       Date:  2009-03       Impact factor: 2.802

View more
  6 in total

1.  Pilot study of a culturally sensitive intervention to promote genetic counseling for breast cancer risk.

Authors:  Vida Henderson; Jessica M Madrigal; Le' Chaun Kendall; Pooja Parekh; Jennifer Newsome; Ifeanyi Beverly Chukwudozie; De Lawnia Comer-Hagans; Vickii Coffey; Giesela Grumbach; Shirley Spencer; Carolyn Rodgers; Ravneet Kaur; Lara Balay; Tara Maga; Zo Ramamonjiarivelo; Catherine Balthazar; Robert Winn; Karriem Watson; Angela Odoms-Young; Kent F Hoskins
Journal:  BMC Health Serv Res       Date:  2022-06-25       Impact factor: 2.908

2.  Healthcare Predictors of Information Dissemination About Genetic Risks.

Authors:  Vida Henderson; Shaila M Strayhorn; Nyahne Q Bergeron; Desmona C Strahan; Pamela S Ganschow; Aditya S Khanna; Karriem Watson; Kent Hoskins; Yamile Molina
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 2.339

3.  Population screening to identify women at risk for hereditary breast cancer syndromes: The path forward or the road not taken?

Authors:  Vida Henderson; Pam Ganschow; Catharine Wang; Kent F Hoskins
Journal:  Cancer       Date:  2021-08-23       Impact factor: 6.860

4.  Patient and Clinician Decision Support to Increase Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome in Primary Care: A Cluster Randomized Clinical Trial.

Authors:  Rita Kukafka; Samuel Pan; Thomas Silverman; Tianmai Zhang; Wendy K Chung; Mary Beth Terry; Elaine Fleck; Richard G Younge; Meghna S Trivedi; Julia E McGuinness; Ting He; Jill Dimond; Katherine D Crew
Journal:  JAMA Netw Open       Date:  2022-07-01

5.  Association of Population Screening for Breast Cancer Risk With Use of Mammography Among Women in Medically Underserved Racial and Ethnic Minority Groups.

Authors:  Candice Schwartz; Ifeanyi Beverly Chukwudozie; Silvia Tejeda; Ganga Vijayasiri; Ivy Abraham; Mylene Remo; Hiral A Shah; Maria Rojas; Alicia Carillo; Loraine Moreno; Richard B Warnecke; Kent F Hoskins
Journal:  JAMA Netw Open       Date:  2021-09-01

6.  Increasing access to individualized medicine: a matched-cohort study examining Latino participant experiences of genomic screening.

Authors:  Joel E Pacyna; Gabriel Q Shaibi; Alex Lee; Jamie O Byrne; Idali Cuellar; Erica J Sutton; Valentina Hernandez; Noralane M Lindor; Davinder Singh; Iftikhar J Kullo; Richard R Sharp
Journal:  Genet Med       Date:  2021-01-26       Impact factor: 8.822

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.